Wedbush initiated coverage on shares of Eupraxia Pharmaceuticals (NASDAQ:EPRX – Free Report) in a report released on Thursday, Marketbeat Ratings reports. The brokerage issued an outperform rating and a $17.00 price target on the stock. A number of other equities research analysts have also weighed in on EPRX. Stifel Nicolaus set a $25.00 price objective […]

Wedbush started coverage on shares of Eupraxia Pharmaceuticals (NASDAQ:EPRX – Get Free Report) in a note issued to investors on Thursday, Benzinga reports. The firm set an “outperform” rating and a $17.00 price target on the stock. Wedbush’s target price indicates a potential upside of 108.85% from the stock’s current price. Other research analysts have […]